PMC:7358770 / 33363-33547
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T323","span":{"begin":109,"end":122},"obj":"Body_part"},{"id":"T324","span":{"begin":163,"end":178},"obj":"Body_part"}],"attributes":[{"id":"A323","pred":"fma_id","subj":"T323","obj":"http://purl.org/sig/ont/fma/fma82784"},{"id":"A324","pred":"fma_id","subj":"T324","obj":"http://purl.org/sig/ont/fma/fma82746"}],"text":"ve as innovative adjuvants for enhancing peptide-based vaccine potency through immune enhancement [118]. The glycopeptides prepared by the combination of selected polysaccharides with "}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1125","span":{"begin":109,"end":122},"obj":"Chemical"},{"id":"1126","span":{"begin":163,"end":178},"obj":"Chemical"}],"attributes":[{"id":"A1125","pred":"tao:has_database_id","subj":"1125","obj":"MESH:D006020"},{"id":"A1126","pred":"tao:has_database_id","subj":"1126","obj":"MESH:D011134"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ve as innovative adjuvants for enhancing peptide-based vaccine potency through immune enhancement [118]. The glycopeptides prepared by the combination of selected polysaccharides with "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T371","span":{"begin":41,"end":48},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"ve as innovative adjuvants for enhancing peptide-based vaccine potency through immune enhancement [118]. The glycopeptides prepared by the combination of selected polysaccharides with "}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T496","span":{"begin":17,"end":26},"obj":"Chemical"},{"id":"T497","span":{"begin":41,"end":48},"obj":"Chemical"},{"id":"T498","span":{"begin":109,"end":122},"obj":"Chemical"},{"id":"T499","span":{"begin":163,"end":178},"obj":"Chemical"}],"attributes":[{"id":"A496","pred":"chebi_id","subj":"T496","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"},{"id":"A497","pred":"chebi_id","subj":"T497","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A498","pred":"chebi_id","subj":"T498","obj":"http://purl.obolibrary.org/obo/CHEBI_24396"},{"id":"A499","pred":"chebi_id","subj":"T499","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"}],"text":"ve as innovative adjuvants for enhancing peptide-based vaccine potency through immune enhancement [118]. The glycopeptides prepared by the combination of selected polysaccharides with "}
2_test
{"project":"2_test","denotations":[{"id":"32679328-20541583-48281346","span":{"begin":99,"end":102},"obj":"20541583"},{"id":"T82869","span":{"begin":99,"end":102},"obj":"20541583"}],"text":"ve as innovative adjuvants for enhancing peptide-based vaccine potency through immune enhancement [118]. The glycopeptides prepared by the combination of selected polysaccharides with "}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T955","span":{"begin":17,"end":26},"obj":"CHEBI:60809;CHEBI:60809"},{"id":"T956","span":{"begin":79,"end":85},"obj":"UBERON:0002405"},{"id":"T957","span":{"begin":109,"end":122},"obj":"CHEBI:24396;CHEBI:24396"},{"id":"T958","span":{"begin":163,"end":178},"obj":"CHEBI:18154;CHEBI:18154"},{"id":"T50142","span":{"begin":26,"end":39},"obj":"NCBITaxon:11118"},{"id":"T76167","span":{"begin":92,"end":107},"obj":"CHEBI:18154;CHEBI:18154"},{"id":"T26865","span":{"begin":148,"end":157},"obj":"CHEBI:75958;CHEBI:75958"}],"text":"ve as innovative adjuvants for enhancing peptide-based vaccine potency through immune enhancement [118]. The glycopeptides prepared by the combination of selected polysaccharides with "}
MyTest
{"project":"MyTest","denotations":[{"id":"1125","span":{"begin":109,"end":122},"obj":"Chemical"},{"id":"1126","span":{"begin":163,"end":178},"obj":"Chemical"}],"attributes":[{"id":"A1125","pred":"tao:has_database_id","subj":"1125","obj":"MESH:D006020"},{"id":"A1126","pred":"tao:has_database_id","subj":"1126","obj":"MESH:D011134"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"ve as innovative adjuvants for enhancing peptide-based vaccine potency through immune enhancement [118]. The glycopeptides prepared by the combination of selected polysaccharides with "}